Trial Profile
Rosuvastatin affecting aortic valve endothelium - RAAVE
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2006
Price :
$35
*
At a glance
- Drugs Rosuvastatin (Primary)
- Indications Hypercholesterolaemia
- Focus Biomarker; Pharmacodynamics
- Acronyms RAAVE
- 03 Nov 2006 Status change
- 19 Nov 2005 New trial record.